Error: Could not add to watchlist. X
+ Watchlist

RegeneRx Biopharmaceuticals Inc

RRX:GR
Frankfurt
0.22
EUR
0.01
3.48%
As of 2:05 AM EDT 8/23/2017
Open
0.22
Day Range
0.22 - 0.22
Volume
0
Previous Close
0.23
52Wk Range
0.21 - 0.38
1 Yr Return
-32.32%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
0.22
Day Range
0.22 - 0.22
Volume
0
Previous Close
0.23
52Wk Range
0.21 - 0.38
1 Yr Return
-32.32%
YTD Return
-26.97%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (m EUR)
23.728
Shares Outstanding (m)
106.883
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
+1.17%
% Price Change
+1.33%

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
RegeneRx Biopharmaceuticals, Inc. is focusing on the commercialization of Thymosin beta 4, a 43 amino acid peptide. The Company is concentrating its efforts on the use of Thymosin beta 4 for the treatment of injured tissue and non-healing wounds to enable more rapid repair and/or tissue regeneration.
Address
15245 Shady Grove Road
Suite 470
Rockville, MD 208150
United States
Phone
1-301-208-9191
Show More